{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:52:32Z","timestamp":1790949152877,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00277-018-3419-1","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T20:58:01Z","timestamp":1530824281000},"page":"2173-2183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)"],"prefix":"10.1007","volume":"97","author":[{"name":"Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1496-376X","authenticated-orcid":false,"given":"Takaaki","family":"Konuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuho","family":"Najima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiwa","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishikazu","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"3419_CR1","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","volume":"96","author":"ML Slovak","year":"2000","unstructured":"Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR (2000) Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study. Blood 96:4075\u20134083","journal-title":"Blood"},{"key":"3419_CR2","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","volume":"100","author":"JC Byrd","year":"2002","unstructured":"Byrd JC, Mr\u00f3zek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, Pettenati MJ, Patil SR, Rao KW, Watson MS, Koduru PR, Moore JO, Stone RM, Mayer RJ, Feldman EJ, Davey FR, Schiffer CA, Larson RA, Bloomfield CD, Cancer and Leukemia Group B (CALGB 8461) (2002) Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100:4325\u20134336","journal-title":"Blood"},{"key":"3419_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"D Grimwade","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, Wheatley K, Harrison CJ, Burnett AK, on behalf of the National Cancer Research Institute Adult Leukaemia Working Group (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116:354\u2013365","journal-title":"Blood"},{"key":"3419_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, Levine RL, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz M, Sierra J, Tallman MS, Tien HF, Wei AH, L\u00f6wenberg B, Bloomfield CD (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129:424\u2013447","journal-title":"Blood"},{"key":"3419_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.1365-2141.2002.03724.x","volume":"118","author":"AK Burnett","year":"2002","unstructured":"Burnett AK, Wheatley K, Goldstone AH, Stevens RF, Hann IM, Rees JH et al (2002) The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol 118:385\u2013400","journal-title":"Br J Haematol"},{"key":"3419_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1182\/blood-2006-10-043299","volume":"110","author":"MS Tallman","year":"2007","unstructured":"Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM, Litzow MR, Mehta J, Pedersen T, Perez WS, Rowe JM, Wetzler M, Weisdorf DJ (2007) Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood 110:409\u2013417","journal-title":"Blood"},{"issue":"6","key":"3419_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.bbmt.2007.01.079","volume":"13","author":"Philippe Armand","year":"2007","unstructured":"Armand P, Kim HT, DeAngelo DJ, Ho VT, Cutler CS, Stone RM et al (2007) Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation. Biol Blood Marrow Transplant 13:655\u2013664","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"3419_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbmt.2011.07.024","volume":"18","author":"P Armand","year":"2012","unstructured":"Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten HC, Finke J, Ball ED, Aljurf MD, Cutler CS, Rowe JM, Antin JH, Isola LM, di Bartolomeo P, Camitta BM, Miller AM, Cairo MS, Stockerl-Goldstein K, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes DW, Petersdorf EW, Devine SM, Maziarz RT, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer RJ, Weisdorf DJ (2012) Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a center for international blood and marrow transplant research study. Biol Blood Marrow Transplant 18:280\u2013288","journal-title":"Biol Blood Marrow Transplant"},{"key":"3419_CR9","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood.V90.11.4532","volume":"90","author":"K Mr\u00f3zek","year":"1997","unstructured":"Mr\u00f3zek K, Heinonen K, Lawrence D, Carroll AJ, Koduru PR, Rao KW et al (1997) Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood 90:4532\u20134538","journal-title":"Blood"},{"key":"3419_CR10","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1200\/JCO.2008.16.7981","volume":"27","author":"J Krauter","year":"2009","unstructured":"Krauter J, Wagner K, Sch\u00e4fer I, Marschalek R, Meyer C, Heil G, Schaich M, Ehninger G, Niederwieser D, Krahl R, B\u00fcchner T, Sauerland C, Schlegelberger B, D\u00f6hner K, D\u00f6hner H, Schlenk RF, Ganser A (2009) Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol 27:3000\u20133006","journal-title":"J Clin Oncol"},{"key":"3419_CR11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/cncr.20489","volume":"101","author":"W Blum","year":"2004","unstructured":"Blum W, Mr\u00f3zek K, Ruppert AS, Carroll AJ, Rao KW, Pettenati MJ, Anastasi J, Larson RA, Bloomfield CD (2004) Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature. Cancer 101:1420\u20131427","journal-title":"Cancer"},{"key":"3419_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/bmt.2008.200","volume":"42","author":"H Tamai","year":"2008","unstructured":"Tamai H, Yamaguchi H, Takahashi S, Tojo A, Hamaguchi H, Kobayashi T, Akiyama H, Sakamaki H, Okumura H, Nakao S, Arai A, Miura O, Tajika K, Inokuchi K, Dan K (2008) Treatment of adult AML with t(6;11)(q27;q23) by allogeneic hematopoietic SCT in the first CR. Bone Marrow Transplant 42:553\u2013554","journal-title":"Bone Marrow Transplant"},{"key":"3419_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12185-008-0034-2","volume":"87","author":"H Tamai","year":"2008","unstructured":"Tamai H, Yamaguchi H, Hamaguchi H, Yagasaki F, Bessho M, Kobayashi T, Akiyama H, Sakamaki H, Takahashi S, Tojo A, Ohmine K, Ozawa K, Okumura H, Nakao S, Arai A, Miura O, Toyota S, Gomi S, Murai Y, Usui N, Miyazawa K, Ohyashiki K, Takahashi N, Sawada K, Kato A, Oshimi K, Inokuchi K, Dan K (2008) Clinical features of adult acute leukemia with 11q23 abnormalities in Japan: a co-operative multicenter study. Int J Hematol 87:195\u2013202","journal-title":"Int J Hematol"},{"key":"3419_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ajh.23619","volume":"89","author":"Y Wang","year":"2014","unstructured":"Wang Y, Liu QF, Qin YZ, Liu DH, Xu LP, Jiang B, Jiang Q, Dai M, Yu SJ, Jiang XM, Liu YR, Huang XJ (2014) Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of patients with mixed-lineage-leukemia-rearranged acute leukemia: results from a prospective, multi-center study. Am J Hematol 89:130\u2013136","journal-title":"Am J Hematol"},{"key":"3419_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12185-015-1779-z","volume":"102","author":"T Muto","year":"2015","unstructured":"Muto T, Takeuchi M, Yamazaki A, Sugita Y, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Ohwada C, Sakaida E, Aotsuka N, Iseki T, Nakaseko C (2015) Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia. Int J Hematol 102:86\u201392","journal-title":"Int J Hematol"},{"key":"3419_CR16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/leu.2012.319","volume":"27","author":"Y Chen","year":"2013","unstructured":"Chen Y, Kantarjian H, Pierce S, Faderl S, O\u2019Brien S, Qiao W, Abruzzo L, de Lima M, Kebriaei P, Jabbour E, Daver N, Kadia T, Estrov Z, Garcia-Manero G, Cortes J, Ravandi F (2013) Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation. Leukemia 27:836\u2013842","journal-title":"Leukemia"},{"key":"3419_CR17","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1038\/leu.2015.143","volume":"29","author":"A Pigneux","year":"2015","unstructured":"Pigneux A, Labopin M, Maertens J, Cordonnier C, Volin L, Soci\u00e9 G et al (2015) Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23\/MLL rearrangement (MLL-r AML). Leukemia 29:2375\u20132381","journal-title":"Leukemia"},{"key":"3419_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF03006932","volume":"86","author":"Y Atsuta","year":"2007","unstructured":"Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, Kato K, Tabuchi K, Tsuchida M, Morishima Y, Mitamura M, Kawa K, Kato S, Nagamura T, Takanashi M, Kodera Y (2007) Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol 86:269\u2013274","journal-title":"Int J Hematol"},{"key":"3419_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","volume":"103","author":"Y Atsuta","year":"2016","unstructured":"Atsuta Y (2016) Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol 103:3\u201310","journal-title":"Int J Hematol"},{"key":"3419_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","volume":"103","author":"J Kanda","year":"2016","unstructured":"Kanda J (2016) Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation. Int J Hematol 103:11\u201319","journal-title":"Int J Hematol"},{"issue":"3","key":"3419_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"Sergio Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B (2009) Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 15:367\u2013369","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"3419_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"3419_CR23","first-page":"1626","volume":"90","author":"C Scholl","year":"2005","unstructured":"Scholl C, Schlenk RF, Eiwen K, D\u00f6hner H, Fr\u00f6hling S, D\u00f6hner K, AML Study Group (2005) The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia. Haematologica 90:1626\u20131634","journal-title":"Haematologica"},{"key":"3419_CR24","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","volume":"359","author":"CH Pui","year":"2002","unstructured":"Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W, Silverman LB, Biondi A, Harms DO, Vilmer E, Schrappe M, Camitta B (2002) Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 359:1909\u20131915","journal-title":"Lancet"},{"key":"3419_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","volume":"370","author":"R Pieters","year":"2007","unstructured":"Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M et al (2007) A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 370:240\u2013250","journal-title":"Lancet"},{"key":"3419_CR26","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","volume":"114","author":"BV Balgobind","year":"2009","unstructured":"Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJL, Leszl A, Litvinko N, Nigro LL, Morimoto A, Perot C, Pieters R, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Zwaan CM, van den Heuvel-Eibrink MM (2009) Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 114:2489\u20132496","journal-title":"Blood"},{"key":"3419_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0145-2126(00)00011-4","volume":"24","author":"SM Garrido","year":"2000","unstructured":"Garrido SM, Bryant E, Appelbaum FR (2000) Allogeneic stem cell transplantation for relapsed and refractory acute myeloid leukemia patients with 11q23 abnormalities. Leuk Res 24:481\u2013486","journal-title":"Leuk Res"},{"key":"3419_CR28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1056\/NEJMoa1602074","volume":"375","author":"F Milano","year":"2016","unstructured":"Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, Witherspoon R, Mielcarek M, Deeg JH, Sorror M, Dahlberg A, Sandmaier BM, Salit R, Petersdorf E, Appelbaum FR, Delaney C (2016) Cord-blood transplantation in patients with minimal residual disease. N Engl J Med 375:944\u2013953","journal-title":"N Engl J Med"},{"key":"3419_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.bbmt.2015.10.006","volume":"22","author":"S Terakura","year":"2016","unstructured":"Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Najima Y, Fukuda T, Uchida N, Takahashi S, Nagamura-Inoue T, Morishima Y, Miyamura K, Japan Society for Hematopoietic Cell Transplantation (2016) Comparison of outcomes of 8\/8 and 7\/8 allele-matched unrelated bone marrow transplantation and single-unit cord blood transplantation in adults with acute leukemia. Biol Blood Marrow Transplant 22:330\u2013338","journal-title":"Biol Blood Marrow Transplant"},{"key":"3419_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","volume":"11","author":"M Eapen","year":"2010","unstructured":"Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE, Center for International Blood and Marrow Transplant Research, Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation), National Cord Blood Program of the New York Blood Center (2010) Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 11:653\u2013660","journal-title":"Lancet Oncol"},{"key":"3419_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1600-0609.2008.01057.x","volume":"80","author":"T Konuma","year":"2008","unstructured":"Konuma T, Ooi J, Takahashi S, Tomonari A, Tsukada N, Kato S, Kasahara S, Uchimaru K, Iseki T, Tojo A, Asano S (2008) Myeloablative unrelated cord blood transplantation for adult acute myeloid leukemia patients with 11q23 abnormalities. Eur J Haematol 80:545\u2013548","journal-title":"Eur J Haematol"},{"key":"3419_CR32","doi-asserted-by":"crossref","unstructured":"Meyer C, Burmeister T, Gr\u00f6ger D, Tsaur G, Fechina L, Renneville A et al (2018) The MLL recombinome of acute leukemias in 2017. Leukemia 32:273\u2013284","DOI":"10.1038\/leu.2017.213"},{"key":"3419_CR33","unstructured":"O\u2019Donnell MR, Tallman MS, Abboud CN, et al (2016) National comprehensive cancer network. NCCN clinical practice guidelines in oncology. Acute Myeloid Leukemia Version 1. [cited 2016 Feb 16] Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp"},{"key":"3419_CR34","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1182\/blood-2003-02-0434","volume":"102","author":"C Schoch","year":"2003","unstructured":"Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, Haferlach T (2003) AML with 11q23\/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 102:2395\u20132402","journal-title":"Blood"},{"key":"3419_CR35","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2002-05-1459","volume":"101","author":"S Barjesteh van Waalwijk van Doorn-Kh","year":"2003","unstructured":"Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R et al (2003) High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 101:837\u2013845","journal-title":"Blood"},{"key":"3419_CR36","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1200\/JCO.2009.26.0646","volume":"28","author":"S Gr\u00f6schel","year":"2010","unstructured":"Gr\u00f6schel S, Lugthart S, Schlenk RF, Valk PJ, Eiwen K, Goudswaard C et al (2010) High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. J Clin Oncol 28:2101\u20132107","journal-title":"J Clin Oncol"},{"key":"3419_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1200\/JCO.2011.41.5505","volume":"31","author":"S Gr\u00f6schel","year":"2013","unstructured":"Gr\u00f6schel S, Schlenk RF, Engelmann J, Rockova V, Teleanu V, K\u00fchn MW et al (2013) Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON\/SAKK Cooperative Group. J Clin Oncol 31:95\u2013103","journal-title":"J Clin Oncol"},{"key":"3419_CR38","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.bbmt.2014.03.008","volume":"20","author":"J Liu","year":"2014","unstructured":"Liu J, Wang Y, Xu LP, Liu DH, Qin YZ, Chang YJ, Liu KY, Huang XJ (2014) Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia\u2014rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20:929\u2013936","journal-title":"Biol Blood Marrow Transplant"},{"key":"3419_CR39","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2141.2006.06301.x","volume":"135","author":"J Basecke","year":"2006","unstructured":"Basecke J, Whelan JT, Griesinger F, Bertrand FE (2006) The MLL partial tandem duplication in acute myeloid leukaemia. Br J Haematol 135:438\u2013449","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3419-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3419-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3419-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T07:41:29Z","timestamp":1571557289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3419-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3419"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3419-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"9 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}